← Open Payments lookup

JAMIE JADID: Open Payments

NPI 1245559061 · LAS VEGAS, NV. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$4,067 in 101 payments from 27 companies in 2025. Trend: 2023 $2,833 · 2024 $3,006 · 2025 $4,067

Food & beverage: $2,872Travel & lodging: $1,194
CompanyPaymentsAmount
Medtronic, Inc.10$1,521
BETA BIONICS, INC.10$402
Novo Nordisk Inc14$363
Ascendis Pharma Endocrinology Inc5$202
KYOWA KIRIN, INC.2$155
Amgen Inc.9$153
Dexcom, Inc.7$149
Bayer Healthcare Pharmaceuticals Inc.10$147
Tandem Diabetes Care, Inc.1$101
Xeris Pharmaceuticals, Inc.5$97

Products named: MINIMED 780G, iLet Bionic Pancreas, Yorvipath, Ozempic, Dexcom G6 Transmitter, Kerendia, Repatha, t:slim X2 Insulin Pump with Control-IQ.

Industry payments across NV — which companies pay providers there.